189 related articles for article (PubMed ID: 31683939)
1. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.
Banaszkiewicz M; Małyszko J; Vesole DH; Woziwodzka K; Jurczyszyn A; Żórawski M; Krzanowski M; Małyszko J; Batko K; Kuźniewski M; Krzanowska K
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683939
[TBL] [Abstract][Full Text] [Related]
2. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
Belo L; Rocha S; Valente MJ; Coimbra S; Catarino C; Bronze-da-Rocha E; Rocha-Pereira P; do Sameiro-Faria M; Oliveira JG; Madureira J; Fernandes JC; Miranda V; Santos-Silva A
Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
[No Abstract] [Full Text] [Related]
5. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
Drakou A; Margeli A; Theodorakopoulou S; Agrogiannis I; Poziopoulos C; Papassotiriou I; Vlahakos DV
Blood Cells Mol Dis; 2016 Jul; 59():100-5. PubMed ID: 27282576
[TBL] [Abstract][Full Text] [Related]
6. [Inadequate erythropoietin production (epo) in patients with multiple myeloma].
Kostova G; Siljanovski N
Prilozi; 2004; 25(1-2):53-66. PubMed ID: 15735535
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of serum transferrin receptor concentration in diagnosing and differentiating iron deficiency anaemia from anaemia of chronic disorders.
Hanif E; Ayyub M; Anwar M; Ali W; Bashir M
J Pak Med Assoc; 2005 Jan; 55(1):13-6. PubMed ID: 15816689
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker.
van der Weerd NC; Grooteman MP; Nubé MJ; ter Wee PM; Swinkels DW; Gaillard CA
Neth J Med; 2015 Mar; 73(3):108-18. PubMed ID: 25852110
[TBL] [Abstract][Full Text] [Related]
9. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
10. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.
Nakanishi T; Kimura T; Kuragano T
Contrib Nephrol; 2019; 198():124-134. PubMed ID: 30991414
[TBL] [Abstract][Full Text] [Related]
11. Beyond soluble transferrin receptor: old challenges and new horizons.
Harms K; Kaiser T
Best Pract Res Clin Endocrinol Metab; 2015 Oct; 29(5):799-810. PubMed ID: 26522463
[TBL] [Abstract][Full Text] [Related]
12. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
13. Soluble transferrin receptor, ferritin and soluble transferrin receptor--Ferritin index in assessment of anaemia in rhaeumatoid arthritis.
Pavai S; Jayaranee S; Sargunan S
Med J Malaysia; 2007 Oct; 62(4):303-7. PubMed ID: 18551934
[TBL] [Abstract][Full Text] [Related]
14. Serum transferrin receptor, serum ferritin and serum transferrin receptor-ferritin index in adults with iron deficiency anaemia.
Nadeem S; Shah S; Iqbal T; Iqbal Z; Hanif E
J Ayub Med Coll Abbottabad; 2011; 23(3):44-6. PubMed ID: 23272433
[TBL] [Abstract][Full Text] [Related]
15. Iron Status and Inflammation in Early Stages of Chronic Kidney Disease.
Łukaszyk E; Łukaszyk M; Koc-Żórawska E; Tobolczyk J; Bodzenta-Łukaszyk A; Małyszko J
Kidney Blood Press Res; 2015; 40(4):366-73. PubMed ID: 26160488
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble transferrin receptor in hypochromic microcytic anaemia.
Jayaranee S; Sthaneshwar P
Singapore Med J; 2006 Feb; 47(2):138-42. PubMed ID: 16435056
[TBL] [Abstract][Full Text] [Related]
17. Serum transferrin receptor assay in iron deficiency anaemia and anaemia of chronic disease in the elderly.
Chua E; Clague JE; Sharma AK; Horan MA; Lombard M
QJM; 1999 Oct; 92(10):587-94. PubMed ID: 10627880
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
[No Abstract] [Full Text] [Related]
19. Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial.
Gummer J; Trengove R; Pascoe EM; Badve SV; Cass A; Clarke P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW; Olynyk JK; Ferrari P;
Nephrology (Carlton); 2017 Jul; 22(7):548-554. PubMed ID: 27171136
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]